Papaverine, Solution for Injection, 20 Mg/Ml, 2 Ml Tender - 143957967

Procurement Summary

Country: Ukraine

Summary: Papaverine, Solution for Injection, 20 Mg/Ml, 2 Ml Each; Metamizole Sodium, Solution for Injection, 500 Mg/Ml, 2 Ml; Diclofenac Solution for Injection 25 Mg/Ml; Ketorolac Solution for Injection, 30 Mg/Ml, 1 Ml Each; Me...

Deadline: 26 Jun 2026

Posting Date: 25 Jun 2026

Other Information

Notice Type: Tender

TOT Ref.No.: 143957967

Document Ref. No.: UA-2026-06-23-000882-a

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: UAH 95000

CPV Classification

33610000 - Medicinal products for the alimentary tract and metabolism
33600000 - Pharmaceutical products
33660000 - Medicinal products for the nervous system and sensory organs
33630000 - Medicinal products for dermatology and the musculo-skeletal system

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_detailsLogin to see details

Tender Details

Papaverine, solution for injection, 20 mg/ml, 2 ml each; Metamizole sodium, solution for injection, 500 mg/ml, 2 ml; Diclofenac solution for injection 25 mg/ml; Ketorolac solution for injection, 30 mg/ml, 1 ml each; Metoclopramide, solution for injection, 5 mg/ml, 2 ml each; Cefazolin, powder for injections of 1 g; Electrolytes and combinations solution for infusions 500 ml (Magnesium chloride hexahydrate: 0.2 mg/ml, Potassium chloride: 0.3 mg/ml, Calcium chloride dihydrate: 0.37 mg/ml, Sodium chloride: 6.8 mg/ml, L-malonic acids, Sodium acetate trihydrate: 3.27 mg/ml); Furosemide, solution for injection, 10 mg/ml, 2 ml each; Potassium asparaginate/Magnesium asparaginate solution for injections of 10 ml; Water for injections ampoules of 5 ml; Sodium chloride, solution for infusions, 9 mg/ml 100 ml; Sodium chloride, solution for infusion, 9 mg/ml 200 ml; Electrolytes in combination with Sorbitol 60 mg/1 ml solution for infusions of 200 ml; Sulfocamphocaine solution for injection, 100 mg/ml in 2 ml; Ascorbic acid solution for injection, 50 mg/ml in 2 ml; Glucose solution for infusions 5% in 200 ml; Captopril/hydrochlorothiazide, tablets, 50/12.5 mg each; Ceftazidime, powder for injection 1.0 g; Magnesium sulfate, solution for injection, 250 mg/ml, 5 ml each; Mannitol solution for infusions 150 mg/ml 200 ml; Atropine sulfate solution for injection 1 mg/1 ml, in ampoule 1 ml; Trisol solution for infusions of 200 ml; Diphenhydramine, solution for injection, 10 mg/ml, 1 ml each; Theophylline solution for injection 20 mg/ml in 5 ml; Dexamethasone, solution for injection 4mg/ml; Ceftriaxone, powder for injection for ... Purchase type: goods Classifier and its corresponding code: DK 021:2015: 33600000-6 — Pharmaceutical products Classification according to INN: Electrolytes, Classification according to ATX: B05BB01, Release form: Solution for infusions, Type of packaging: Container, Volume: 500 ml, Magnesium chloride hexahydrate: 0.2 mg/ml, Potassium chloride: 0.3 mg/ml, Cal...

Documents

 Tender Notice